RxDoctor Payments Data

Brian Hendricks, DO

Otolaryngology/Facial Plastic Surgery · Kansas City, MONPI 1770748931

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,910 of the $5,689 with a category attached, or 68.7%. 29 manufacturers reported payments, led by Intersect ENT, Inc. at 45.2% of the total. Reporting peaked in 2019 at $2,665 and has fallen 64.2% since, to $953 in 2025.

$5,689in general payments, 2019–2025

Across 156 payments — averaging $36.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intersect ENT, Inc.$3K
  • GSK$667
  • Optinose US, Inc.$487
  • Aerin Medical Inc.$396
  • Regeneron Healthcare Solutions, Inc.$213
  • Sanofi$186
  • plus $1K from 23 others

What the payments were for

  • Travel & lodging$1,72630%
  • Food & beverage$3,91069%
  • Education$531%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otolaryngology/facial plastic surgery providers in Missourito place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$175,466
Medicare patients
459
Services billed
2,317

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab32$128,119
Ipratropium Bromide243$7,789
Dexamethasone96$3,755
Mupirocin144$2,663
Famotidine132$2,183
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth14$1,588
Omeprazole142$1,173
Fluocinolone Acetonide Oil31$1,013
Amitriptyline Hcl15$676
Fluticasone Propionate30$660
Ofloxacin32$546
Pantoprazole Sodium41$456
Clindamycin Hcl28$351
Clotrimazole16$351
Levofloxacin29$304

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →